PPD CorEvitas Obesity Registry
More than 100 million adults—including over two in five in the U.S—are living with obesity.1 As the number of people using obesity treatments rises at an unprecedented pace, understanding the real-world impact, safety and effectiveness of these therapies is critical.
The PPD™ CorEvitas™ Obesity Registry offers a unique, longitudinal view of individuals receiving obesity-related care and treatment. Through continuous real-world data collection and analysis, this registry helps sponsors, clinicians and regulators gain deep insights into treatment patterns and outcomes, patient experiences and long-term safety in real-world clinical settings.
Get in touch to learn how we can support your obesity treatment studies
Now enrolling qualified sites for our obesity registry
CorEvitas Obesity Registry
Established in 2025
This treatment-based registry prospectively collects detailed physician-reported and patient-level data to evaluate the long-term, real-world effectiveness and safety of medications used in the treatment of obesity.
The data support research on the natural history of obesity, disease burden, treatment patterns and outcomes (including body composition and occurrence/resolution of comorbidities), providing critical insights into how therapies perform outside controlled clinical settings.
Additionally, this registry captures patient preferences, satisfaction and adherence, offering a holistic view of the patient experience and helping to inform optimized obesity management strategies.
Examples of robust preferences and outcomes measures collected in the CorEvitas Obesity Registry
Clinician-reported outcomes
- Body Mass Index (BMI) and other anthropometric measures (weight, height, waist and hip circumference)
- Bioelectrical Impedance Analysis (BIA) (body composition measures)
Patient-reported outcomes
- BODY-Q Obesity module
- Gastrointestinal Symptom Rating Scale (GSRS)
- Patient Reported Outcomes Measurement Information System Sleep Domain (PROMIS-Sleep)
- Work Productivity and Activity Impairment General Health (WPAI-GH)
- Custom questions on symptoms, eating habits, control and self-esteem
Patient preferences
- Medication Adherence Reporting Scale (MARS-5)
- Global assessments of treatment benefit, satisfaction and willingness to continue (BSW)
- Patient preference data on attribute trade-offs and willingness to pay (discrete choice experiments)
Are you interested in utilizing these data to achieve your research needs?
Join our Registry Investigator Network to improve patient health outcomes
Contact our team
Reference
1. Adult Obesity Facts | Obesity | CDC